Upexi Inc specializes in the development, manufacturing, and distribution of consumer products... Show more
Upexi, Inc. (NASDAQ: UPXI), formerly known as Grove, Inc., is a Tampa, Florida-based company that has evolved into a Solana-focused digital asset treasury firm alongside a legacy consumer-products business. The company's strategy centers on acquiring and holding Solana (SOL) tokens in a disciplined, accretive manner, supplemented by staking rewards and discounted locked-token purchases. As of September 30, 2026, Upexi held approximately 2.35 million SOL, with over 95% of its holdings staked.
On the consumer side, Upexi historically developed, manufactured, and distributed branded products such as LuckyTail pet supplements, PRAX energy solutions, and Cure Mushrooms functional mushroom products. However, the company has been exiting many of these legacy lines and outsourcing manufacturing, warehousing, and logistics, reducing its workforce to roughly 10 employees as it concentrates capital on its Solana treasury strategy—an approach that has drawn comparisons to the bitcoin treasury model popularized by MicroStrategy (MSTR).
Over the last 30 days, UPXI has fallen approximately 33%, declining from a closing price of $1.09 on October 12 to roughly $0.73 in early November. The pullback was not linear: the stock traded near $1.00 through mid-October before a sharper selloff in late October and early November pushed shares to the $0.62–$0.73 range.
The quarterly picture is best described as a round trip. From a mid-August close near $0.79, the stock climbed roughly 60% to a closing peak of $1.26 in late September, with an intraday high above $1.30. Since that peak, shares have reversed sharply, surrendering those gains and trading near their August levels by early November. This volatility reflects both the stock's small float and its sensitivity to the price of Solana, which underpins the value of Upexi's treasury.
Several factors contributed to the stock's 30-day decline. First, weakness in Solana token prices reduced the value of Upexi's digital asset treasury and dampened staking revenue, which had been a key source of income as the company transitioned away from product sales. Digital asset revenue fell to $3.1 million in fiscal Q1 2027 from $6.1 million a year earlier, driven primarily by lower SOL prices.
Second, the company's continued use of its at-the-market equity program diluted existing shareholders. Upexi issued approximately 8.8 million shares for about $10.1 million in gross proceeds during the quarter, expanding the share count and pressuring the stock price.
Third, the fiscal Q1 2027 report released on November 10 underscored the shrinking scale of the legacy business. Total revenue of about $3.48 million missed consensus estimates and declined 62% year over year, with product revenue falling to just $0.4 million as the company exited manufacturing and distribution operations. Although diluted EPS of $0.68 beat expectations, the figure was driven largely by $102 million in non-cash unrealized gains on digital assets rather than operating performance. These dynamics left investors weighing the company's high liability load—total liabilities stood at about $234.3 million—against a treasury-heavy balance sheet.
The broader multi-month trend reflects Upexi's transformation into a cryptocurrency treasury company and the market's evolving response to that strategy. In August and September, shares rallied as investors embraced the Solana treasury narrative and the prospect of accretive capital issuance, mirroring the enthusiasm seen in bitcoin treasury peers. The rally peaked in late September near $1.26.
That optimism faded as Solana's price softened and as quarterly results highlighted the costs of the transition. The fiscal Q4 2026 report in September disclosed a net loss of roughly $246.1 million and negative stockholders' equity, while the most recent quarter showed a sharp contraction in product revenue. Management's cost-cutting initiatives—including refinancing its BitGo credit facility from 11.5% to 7.5% and reducing headcount—improved the expense structure, but dilution and digital asset price swings remained dominant forces. By early November, the stock had returned to the levels where it began the quarter.
Tickeron's Trending AI Robots page curates a selection of the platform's top-performing AI trading bots. While Tickeron offers hundreds of bots that trade thousands of tickers, only the most relevant and best-performing strategies appear in this featured section. Each bot varies in its approach, holding timeframe, and performance metrics, allowing traders to filter by criteria that match their own objectives and risk tolerance. For those interested in systematic, data-driven trading tools, exploring the current lineup can offer a useful starting point for building a more disciplined trading routine.
Looking ahead, the most important variable for Upexi remains the price of Solana, which directly affects the value of its treasury, staking income, and the unrealized gains or losses that dominate its reported earnings. Investors should monitor Solana network activity, institutional adoption, and broader digital asset market conditions. On the corporate side, watch for the pace of ATM equity issuance, any further balance-sheet improvements or refinancing, progress toward staking revenue covering operating expenses, and the company's handling of its substantial liabilities. Regulatory developments affecting digital assets and the availability of capital markets for treasury companies will also be key. These factors carry meaningful risk and are subject to rapid change.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
UPXI moved below its 50-day moving average on October 16, 2026 date and that indicates a change from an upward trend to a downward trend. In 30 of 31 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 90%.
The 10-day moving average for UPXI crossed bearishly below the 50-day moving average on October 20, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UPXI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for UPXI entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where UPXI's RSI Oscillator exited the oversold zone, 27 of 37 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 73%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 20 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +7.55% 3-day Advance, the price is estimated to grow further. Considering data from situations where UPXI advanced for three days, in 205 of 239 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
UPXI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 26 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.976) is normal, around the industry mean (0.974). P/E Ratio (-0.165) is within average values for comparable stocks, (-39.046). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (17.274). Dividend Yield (0.000) settles around the average of (0.979) among similar stocks. P/S Ratio (2.117) is also within normal values, averaging (71.888).
The Tickeron Price Growth Rating for this company is 90 (best 1 - 100 worst), indicating slightly worse than average price growth. UPXI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UPXI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry InternetSoftwareServices